Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Shares, par value (euro)0.12 per share
-
Shares outstanding
-
22,421,536
-
Total 13F shares
-
36,701,197
-
Share change
-
+25,162,921
-
Total reported value
-
$255,777,503
-
Put/Call ratio
-
41%
-
Price per share
-
$6.97
-
Number of holders
-
81
-
Value change
-
+$175,801,081
-
Number of buys
-
47
-
Number of sells
-
38
Institutional Holders of CureVac N.V. - Common Shares, par value (euro)0.12 per share (CVAC) as of Q1 2023
As of 31 Mar 2023,
CureVac N.V. - Common Shares, par value (euro)0.12 per share (CVAC) was held by
81 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
36,701,197 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., PRICE T ROWE ASSOCIATES INC /MD/, Avidity Partners Management LP, CITADEL ADVISORS LLC, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, Bill & Melinda Gates Foundation, NORGES BANK, Camber Capital Management LP, and Balyasny Asset Management L.P..
This page lists
81
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.